EUVIMEDEUVIMED entdecken
Kommentar

Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth

Rita Rubin

JAMA · 2024

DOI: 10.1001/jama.2024.14243 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA, 2024. Verfasst von Rita Rubin. Beteiligte Einrichtung: Lead Senior Staff Writer, Medical News & Perspectives, JAMA. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Flavoring Agents, Menthol, United States Food and Drug Administration. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Medical News story examines the controversy surrounding the FDA’s first authorization of flavored e-cigarettes, in this case menthol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Nicotine Delivery SystemsFlavoring AgentsMentholUnited States Food and Drug AdministrationAdolescentHumansDevice ApprovalRiskUnited StatesPublic HealthMarketingChild HealthAdolescent HealthChildVaping

Substanzen

Flavoring AgentsMenthol

Autor:innen und Institutionen

  • Lead Senior Staff Writer, Medical News & Perspectives, JAMA.

Zitieren

APA

Rubin, R. (2024). Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth. JAMA. https://doi.org/10.1001/jama.2024.14243

Vancouver

Rubin R. Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth. JAMA. 2024. doi:10.1001/jama.2024.14243

BibTeX
@article{Rubin2024,
  author = {Rubin, Rita},
  title = {Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.14243}
}
Kostenlos starten →